Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-021928-96Phase 2Active
Phase 2, randomised, double-blind trial in procedural pain comparing Lambdalina (lidocaine cream 40 mg/g) with Placebo cream (2 arms). Primary endpoints: Change in mean pain score on Visual Analog Scale (VAS) and Safety and tolerability profile of lambdalina vs placebo. Started Jan 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-021928-96.